AKI	Acute kidney injury
AmpC	AmpC β-lactamase
AUC	Area under the concentration–time curve
AUC0–12	Area under the plasma concentration–time curve from 0 to 12 h
AUC0–∞	Area under the plasma concentration–time curve extrapolated to infinity
BSI	Bloodstream infection
CMY	Cephamycinase
CNS	Central nervous system
CSF	Cerebrospinal fluid
CTX-M	Cefotaximase-Munich
ESBL	Extended-spectrum β-lactamase
EUCAST	European Committee on Antimicrobial Susceptibility Testing
fT > MIC	Fraction of time free drug concentration remains above the MIC
HAP	Hospital-acquired pneumonia
IAI	Intra-abdominal infection
ICER	Incremental cost-effectiveness ratio
IM	intramuscular
IV	Intravenous
KPC	Klebsiella pneumoniae carbapenemase
LRTI	Lower respiratory tract infection
MIC	Minimum inhibitory concentration
NDM	New Delhi metallo-β-lactamase
OPAT	Outpatient parenteral antimicrobial therapy
PBP	Penicillin-binding protein
PK/PD	Pharmacokinetic/pharmacodynamic
SC	Subcutaneous
UTI	Urinary tract infection
VIM	Verona integron-mediated metallo-β-lactamase